Target intelligence / Profile preview

Lysosomal membrane lipid raft

Molecular classification
Cellular microdomain, Membrane structure, Lipid-protein complex
01

Overview

The lysosomal membrane and its associated lipid rafts are specialized microdomains within the lysosomal bilayer enriched in cholesterol, sphingolipids, and specific proteins like Lysosomal-associated membrane proteins (Boya & Kroemer, 2008). These rafts serve as critical platforms for the assembly of signaling complexes, most notably the mTORC1 complex, which regulates cell growth and metabolism in response to nutrient availability (Zoncu et al., 2011). In many cancer cells, the lysosomal membrane is destabilized, making it a vulnerable target for lysosomotropic agents that induce lysosomal membrane permeabilization (LMP) and subsequent programmed cell death (Boya & Kroemer, 2008). Additionally, defects in the lipid composition of these rafts are central to the pathogenesis of lysosomal storage disorders, such as Niemann-Pick type C, where cholesterol accumulation disrupts normal trafficking (Platt et al., 2012). Therapeutic strategies targeting these domains include small molecules that alter lysosomal pH, stabilize or destabilize the membrane, or modulate lipid metabolism to restore homeostasis (Settembre et al., 2013). Drugs like hydroxychloroquine and siramesine exploit these properties to treat autoimmune diseases or investigate anti-tumor effects by disrupting lysosomal integrity (Boya & Kroemer, 2008).

Other names
Lysosomal membraneLipid raftsLysosomal lipid microdomainLysosomal membrane raftDetergent-resistant membrane of the lysosome
02

Mechanism of action

Induction of lysosomal membrane permeabilization (LMP), inhibition of lysosomal acidification, and modulation of lipid-protein interactions within membrane microdomains.

03

Biological functions

Signal transductionAutophagyMembrane traffickingCholesterol homeostasisApoptosis
04

Disease associations

CancerLysosomal storage diseaseNeurodegenerative diseaseInfection
05

Safety considerations

RetinopathyCardiotoxicityPhospholipidosisSystemic lysosomal dysfunction
06

Interacting drugs

Hydroxychloroquine

5 more in the full profile.

07

Biomarkers

Lysosomal-associated membrane protein 1 (LAMP1)Lysosomal-associated membrane protein 2 (LAMP2)Cathepsin BCathepsin DGalectin-3

Beyond the preview

Go deeper on Lysosomal membrane lipid raft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal membrane lipid raft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call